N/A N=140 Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle
Pancreatic Cancer · Lymphadenopathy · Gastrointestinal Stromal Tumor
Primary: Diagnostic Yield of EUS-FNB and EUS-FNA — 67.1; 90 percentage of patients
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=44 Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
Pancreatic Cancer
Primary: Procedure Duration Required for Placing the Fiducial Markers — 16; 9 mintues
N/A N=134 SharkCore Versus Acquire FNB
EUS Guided Biopsy
Primary: Is the Acquire Needle Non-inferior Compared to SharkCore Needle in Histologic Yield of the Sample Obtained? — 3; 4; 10; 14 Lesions
N/A N=66 Incorporating Endoscopic Ultrasound and Elastography Towards Improving Outcomes of Pediatric Pancreatitis Management
Chronic Pancreatitis · Acute Recurrent Pancreatitis
Primary: EUS Pancreatic Findings- Rosemont Criteria — 36; 0; 26; 0 percentage of participants
Phase 4 N=20 Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study
Pancreatic Cancer
Primary: The Change in Mean Pain Scale Rating in Patients Following Treatment With 10mL or 20mL of Alcohol Injection — 7.9; 8.4 units on a scale
N/A N=8 AR Projections for Eye-gaze Evaluation in Phantoms
Kidney Stones
Primary: Stone Count — 80; 92 percentage
N/A N=10 Eye Gaze Guidance Evaluation in Phantoms
Kidney Stones
Primary: Completeness of Kidney Exploration — 71; 67 percentage of kidney seen
N/A N=78 Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)
GIST
Primary: Diagnostic Accuracy. — 88; 62 Percentage of participants
Phase 1 N=33 Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms
Neoplasms, Cystic, Mucinous, and Serous
Primary: Number of Participants With Adverse Events as a Measure of Safety and Tolerability — 7; 16 participants
Phase 3 N=121 Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions
Pancreatic Solid Lesions · Pancreatic Mass
Primary: Diagnostic Yield of Capillary Technique — 75.4 percentage of specimen
N/A N=135 Needle Guidance in Ultrasound Guided Nerve Blocks
Elective Knee Surgery
Primary: Time Spent in Performing Ultrasound Guided Femoral Nerve Blocks With InfinitiPlusTM Needle Guidance System — 118; 177 seconds — p=< 0.001
N/A N=40 Comparison of 19g FNA and 19g FNB Needles for EUS-LB
Abnormal Liver Function
Primary: Pre-processing Length of the Longest Piece (LLP) — 1.47; 2.09 centimeter
N/A N=20 19 Versus 22-Gauge Needle for EUS-LB
Diagnoses Diseases · Ultrasound Therapy; Complications · Liver Diseases
Primary: Number of Specimens for Which a Histologic Diagnosis Could be Made Based Upon the Amount of Tissue Obtained With the Needle — 17; 14 specimens
N/A N=21 Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Non-alcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis
Primary: Median Total Specimen Length — 8; 14; 8; 11.5 mm
Phase 4 N=21 Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas
Crohn Disease · Rectal Fistula
Primary: Number of Participants With Durable Fistula Healing — 7; 8 participants